Page last updated: 2024-08-23

etoposide and Medulloblastoma

etoposide has been researched along with Medulloblastoma in 114 studies

Research

Studies (114)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's32 (28.07)18.2507
2000's44 (38.60)29.6817
2010's33 (28.95)24.3611
2020's5 (4.39)2.80

Authors

AuthorsStudies
Dunkel, IJ; Ellison, DW; Ermoian, R; Fouladi, M; Geyer, JR; Goldman, S; Hadley, J; Huang, J; Kilburn, L; Kocak, M; Leary, SES; MacDonald, TJ; Northcott, PA; Olson, JM; Onar-Thomas, A; Phillips, P; Smith, KS; Young Poussaint, T1
Hara, J; Okada, K; Sakamoto, H; Soejima, T; Yamasaki, K1
Erdreich-Epstein, A; Mahdi, MY; Pathania, AS; Ren, X; Shackleford, GM1
Almutereen, M; Elborai, Y; Hafez, H; Lee, MA; Lehmann, L; Maher, OM1
Hara, J; Hirato, J; Okada, K; Sakamoto, H; Soejima, T1
Bartolini, S; Brandes, AA; Franceschi, E; Mascarin, M; Minichillo, S; Mura, A; Tomasello, C; Tosoni, A1
Erdreich-Epstein, A; Fernandez, GE; Moats, RA; Pathania, AS; Ren, X; Shackleford, GM; Tran, A; Xu, J; Zhang, Y1
Abedalthagafi, M; Al-Harbi, M; Mobark, NA; Mosleh, O; Santagata, S; Snuderl, M1
Anurathapan, U; Dhanachai, M; Hansasuta, A; Hongeng, S; Jinawath, A; Khongkhatithum, C; Mahachoklertwattana, P; Pakakasama, S; Sirachainan, N1
Andión, M; Lassaletta, A; Lavarino, C; López-Pino, MA; Madero, L; Perez-Somarriba, M1
Cowman, S; Fan, YN; Pizer, B; Sée, V1
Fillmore, HL; Loveson, KF; Mather, RL1
Abujamra, AL; Brunetto, AL; de Farias, CB; Lenz, G; Nör, C; Roesler, R; Sassi, FA; Schwartsmann, G1
Bauer, D; Biassoni, V; Casanova, M; Catania, S; De Pava, MV; Gandola, L; Indini, A; Massimino, M; Modena, P; Pecori, E; Podda, M; Polastri, D; Rampini, P; Schiavello, E1
Clement, J; Drabick, JJ; Frauenhoffer, E; Rybka, W; Varlotto, J1
Ahn, HS; Kang, HJ; Kim, H; Lee, JW; Park, JD; Park, KD; Shin, HY1
Barnes, P; Burger, P; Chen, Z; Friedman, H; Kun, L; Polkinghorn, WR; Tarbell, NJ; Yock, T; Zhou, T1
Garami, M; Hauser, P; Pócza, T; Schuler, D; Vancsó, I1
Booth, L; Conley, A; Cruickshanks, N; Dent, P; Grant, S; Kukreja, RC; Malkin, M; Poklepovic, A; Roberts, JL1
Fan, YN; Meley, D; Pizer, B; Sée, V1
Alexander, C; Ashford, MB; Garnett, MC; Gellert, PR; Ivanov, DP; Parker, TL; Walker, DA1
Kawaguchi, H; Kobayashi, M; Kurisu, K; Nosaka, R; Sugiyama, K; Takayasu, T; Yamasaki, F1
Bourneau-Martin, D; Drablier, G; Lagarce, L; Lainé-Cessac, P; Le Louet, H; Leguay, Z; Pellier, I1
Abrari, A; Gupta, A; Kumar, A; Patir, R; Vaishya, S1
Craveiro, RB; Dilloo, D; Ehrhardt, M; Goetz, B; Olschewski, M; Pietsch, T; Velz, J1
Aoyama, H; Fujieda, K; Ikeda, J; Ishii, N; Iwasaki, Y; Kashiwamura, M; Sawamura, Y; Shirato, H; Taguchi, H; Yasuda, K1
Chen, SH; Jaing, TH; Lin, KL; Liu, LY; Lui, TN; Tseng, CK1
Acerno, S; Biassoni, V; Casanova, M; Cefalo, G; Collini, P; Ferrari, A; Fossati-Bellani, F; Gandola, L; Luksch, R; Mariani, L; Massimino, M; Meazza, C; Modena, P; Pecori, E; Pignoli, E; Podda, M; Poggi, G; Polastri, D; Potepan, P; Ravagnani, F; Simonetti, F; Solero, CN; Spreafico, F; Terenziani, M1
Berretta, S; Biassoni, V; Cefalo, G; Collini, P; Favre, C; Ferrari, A; Fossati-Bellani, F; Gandola, L; Giangaspero, F; Luksch, R; Massimino, M; Pecori, E; Pignoli, E; Poggi, G; Pollo, B; Riva, D; Sardi, I; Solero, C; Spreafico, F; Terenziani, M1
Allen, J; Chan, KW; Donahue, B; Holmes, E; Jakacki, R; Mehta, M; Miller, DC; Muraszko, K; Prados, M; Puccetti, D; Robertson, P; Rorke, LB; Sposto, R; Vezina, G1
Asphahani, F; Buckmaster, R; Thein, M; Xu, J; Zhang, M1
Broaddus, WC; Fillmore, HL; Kadian, R; Kumar, A; Tye, GW; Van Meter, TE1
Béliveau, R; Berger-Thibault, N; Boivin, D; Gingras, D; Labbé, D; Provençal, M; Rivard, GE; Veitch, R1
Dunkel, IJ; Finlay, JL; Gardner, SL; Garvin, JH; Goldman, S; Shi, W1
Attinà, G; Bertolini, P; Colosimo, C; Lazzareschi, I; Mastrangelo, S; Maurizi, P; Migliorati, R; Pastore, M; Riccardi, R; Rizzo, D; Ruggiero, A1
Kanamori, M; Kumabe, T; Saito, R; Sonoda, Y; Tominaga, T; Yamashita, Y1
McDowell, H; Meley, D; Pizer, B; Sée, V; Spiller, DG; White, MR1
Kanamori, M; Kumabe, T; Saito, R; Sonoda, Y; Tominaga, T; Watanabe, M; Yamashita, Y1
Benesch, M; Deinlein, F; Faldum, A; Fleischhack, G; Gerber, NU; Kortmann, RD; Krauss, J; Kuehl, J; Pietsch, T; Rutkowski, S; von Bueren, AO; von Hoff, K; Warmuth-Metz, M; Zwiener, I1
Bhat, K; Doucette, M; Gu, Y; Hsieh, TC; Kang, JX; Law, B; Liu, X; Qian, SY; Wang, F; Wong, ET; Wu, E; Zhou, S1
Botturi, A; Dimeco, F; Erbetta, A; Fariselli, L; Ferroli, P; Franzini, A; Gaviani, P; Lamperti, E; Milanesi, I; Pollo, B; Salmaggi, A; Silvani, A1
Clifford, SC; Coyle, B; Grundy, R; Levesley, J; Lindsey, JC; Lusher, ME1
Kivivuori, SM; Nygaard, R1
Escalon, E; Melnick, SJ; Nair, SM; Ramachandran, C1
Joung, YS; Kim, JH; Koo, HH; Lee, SH; Lim, DH; Shin, HJ; Son, MH; Suh, YL; Sung, KW; Yoo, KH1
Kellie, SJ; Lockwood, L; Mauger, DC; Pozza, LD; Waters, KD; White, L; Wong, CK1
Chaudhry, A; Forsyth, P; Russell, J; Stewart, DA; Zia, MI1
Baeksgaard, L; Sørensen, JB1
Bailey, CC; Ellison, D; Gilbertson, R; Imeson, J; Ironside, J; Lashford, LS; Lucraft, H; Pizer, BL; Robinson, K; Tait, DM; Taylor, RE; Walker, DA; Weston, CL1
Distel, L; Grabenbauer, G; Holter, W; Neubauer, S; Varon, R1
McLean, TW1
Bailey, CC; Ellison, D; Gilbertson, R; Ironside, J; Lashford, LS; Lucraft, H; Pizer, BL; Robinson, KJ; Saran, F; Tait, DM; Taylor, RE; Walker, DA; Weston, CL1
Chi, SN; Finlay, JL; Gardner, SL; Knopp, EA; Levy, AS; Miller, DC; Weiner, HL; Wisoff, JH1
Bode, U; Deinlein, F; Emser, A; Graf, N; Kortmann, RD; Kuehl, J; Ottensmeier, H; Pietsch, T; Rutkowski, S; Soerensen, N; Warmuth-Metz, M; Wolff, JE1
Cohen, ZR; Fuller, GN; Lang, FF; Majumder, S; Price, RE; Sawaya, R; Su, X1
Mori, H; Nishiyama, K; Takahashi, H; Tanaka, R; Umezu, H; Yoshimura, J1
Alcutt, D; Grogan, L; Morris, P; Nasser, Q; Razak, AR1
Chaku, J; Kellie, SJ; Lockwood, LR; O'Regan, P; Waters, KD; Wong, CK1
Babin, A; Bours, D; Carrie, C; Chastagner, P; Doz, F; Edan, C; Frappaz, D; Gentet, JC; Kalifa, C; Le Gales, C; Mosseri, V; Neuenschwander, S; Oyharcabal-Bourden, V; Pagnier, A; Pichon, F; Ruchoux, M; Sariban, E; Vinchon, M1
Takahashi, H; Tanaka, R1
Axtell, RA; Boyett, JM; Breiger, D; Broxson, E; Donahue, B; Finlay, JL; Geyer, JR; Goldwein, JW; Heier, LA; Jennings, M; Johnson, D; Mazewski, C; Miller, DC; Packer, R; Puccetti, D; Radcliffe, J; Shiminski-Maher, T; Sposto, R; Tao, ML1
Burhenne, J; Foell, JL; Reiss, T; Rengelshausen, J; Staege, MS; Stiefel, M; Wawer, A1
Barnes, P; Chen, Z; Fitzgerald, TJ; Friedman, HS; Glicksman, A; Kepner, JL; Kessel, S; Kun, L; Laurie, F; Miralbell, R; Tarbell, NJ; Urie, M; Zhou, T1
Kamani, N; Lafond, D; Loechelt, B; MacDonald, TJ; Packer, RJ; Perez-Albuerne, E; Rood, B; Thorarinsdottir, HK1
Abe, M; Imamura, J; Kida, Y; Tabuchi, K; Takagi, M; Tokumaru, S1
Bader, P; Beck, JF; Hartwig, C; Heesch, S; Kumar, KS; Maass, M; Müller, C; Sonnemann, J1
Alapetite, C; Bertozzi, AI; Bours, D; Bracard, S; Chastagner, P; Doz, F; Edan, C; Frappaz, D; Gentet, JC; Kalifa, C; Le Gales, C; Mosseri, V; Pagnier, A; Pichon, F; Rialland, X; Sariban, E; Tubiana, AL; Verlooy, J; Zerah, M1
Ahn, SD; Cho, EJ; Choi, ES; Ghim, TT; Koo, HH; Lim, DH; Ra, YS; Shin, HJ; Sung, KW; Yoo, KH1
Hongo, T; Nishizawa, S; Ohzeki, T; Okada, S; Sakaguchi, K; Suzuki, K1
Iwaki, T; Kuga, D; Matsumoto, K; Miyamoto, K; Mizoguchi, M; Niiro, H; Ohta, M; Sasaki, T; Shono, T; Suzuki, SO; Uesaka, T1
Betanzos-Cabrera, Y; Cerecedo-Díaz, F; del Angel, VW; Diegopérez-Ramírez, J; López-Aguilar, E; Rivera-Márquez, H; Sepúlveda-Vildósola, AC; Siordia-Reyes, G1
Choi, LM; Kamani, N; La Fond, D; Macdonald, TJ; Packer, RJ; Rood, B; Santi, MR1
Sterling-Levis, K; White, L1
Ansell, S; Arndt, C; Buckner, J; Christianson, T; Galanis, E; Gill, P; Litzow, M; Moynihan, T1
Abd-El-Aal, HH1
Hotta, T; Kawamoto, K; Kiya, K; Kurisu, K; Mikami, T; Uozumi, T1
Douglass, EC; Gajjar, AJ; Greenwald, C; Heideman, RL; Jenkins, JJ; Kellie, SJ; Kovnar, EH; Langston, JA; Li, Y; Walter, AW1
Bando, K; Kannuki, S; Kuroda, Y; Matsumoto, K; Shirakawa, N; Takaue, Y1
Bouffet, E; Chastagner, P; Doz, F; Gentet, JC; Kalifa, C; Mazingue, F; Plantaz, D; Roché, H; Sariban, E; Tron, P1
Boor, R; Gutjahr, P; Huber, A1
Craver, RD; Gohd, RS; Hierholzer, JC; Sundin, DR1
Chang, TK; Hsien, YL; Hwang, B; Jeng, MJ; Tang, RB; Wong, TT1
Lasorella, A; Mastrangelo, R; Riccardi, R; Tornesello, A1
Ashley, DM; Duffner, PK; Friedman, HS; Gajjar, A; Kerby, T; Kun, L; Longee, D; Meier, L; Smith, S; Zalduondo, FM1
Kowada, M; Mineura, K; Sasajima, T; Takeda, O; Watanabe, A1
Abe, H; Ikeda, J; Ishii, N; Kato, T; Sawamura, Y; Shirato, H; Tada, M1
Asai, Y; Matsushita, K; Naitoh, T; Suetsugu, S1
Borsi, J; Csáki, C; Ferencz, T; Horváth, J; Paál, K; Schuler, D1
Leo, E; Lindemann, A; Schlegel, PG1
Chamberlain, MC; Kormanik, PA1
Allen, JC; Bostrom, BC; Boyett, JM; Dunkel, IJ; Finlay, JL; Gardner, SL; Garvin, JH; Goldman, S; Li, H; Rosenblum, M; Sender, LS; Yates, A1
Benesch, M; Kerbl, R; Lackner, H; Oberbauer, R; Pakisch, B; Schwinger, W; Urban, C1
Alla, P; Carloz, E; de Jauréguiberry, JP; Gisserot, O; Jaubert, D; Valance, J1
de Tribolet, N; Dietrich, PY; Pizzolato, G; Zona, G1
Borsi, JD; Csáki, C; Ferencz, T; Horváth, J; Paál, K; Schuler, D1
Arias-Gomez, J; Cerecedo-Diaz, F; Lopez-Aguilar, E; Quintana-Roldan, G; Rivera-Marquez, H; Santacruz-Castillo, E; Sepulveda-Vildosola, AC; Valdez-Sanchez, M1
Hori, S; Kawashima, H; Mori, T; Morikawa, N; Takeyama, M1
Plummer, ER; Roberts, JT1
Carapella, C; Castello, MA; Maurizi, P; Schiavetti, A; Trasimeni, G; Varrasso, G1
Bondiau, PY; Foa, C; Magné, N; Otto, J; Thyss, A1
Chamberlain, MC; Glantz, MJ; Greenberg, HS; Wang, S1
Mazeron, JJ; Noël, G1
Bode, U; Fleischhack, G; Hasan, C; Hettmer, S; Jaehde, U; Reif, S1
Alfieri, E; Cirillo, S; D'Amore, R; Fiorillo, A; Greco, N; Maggi, G; Marano, I; Martone, A; Migliorati, R1
Ashley, DM; Chow, CW; Gray, AZ; Hawkins, CJ; Riffkin, CD1
Dhodapkar, K; Dunkel, IJ; Finlay, J; Gardner, S; Sapp, M; Thoron, L1
Ash, RC; Beatty, PA; Lundberg, JH; Weissman, DE1
Kanai, H; Mabe, H; Nagai, H; Wakabayashi, S; Yamashita, N1
Hamano, S; Izawa, I; Kokunai, T; Kudo, H; Kuwamura, K; Matsumoto, S; Sawa, H; Tamaki, N; Tatsumi, S1
Lihou, MG; Smith, PJ; Tomlinson, FH1
Carson, BS; Corden, BJ; Killmond, T; Kumar, AJ; Phillips, PC; Piantadosi, S; Robb, PA; Strauss, LC; Wharam, MD1
Douglass, EC; Etcubanas, EE; Fairclough, DL; Horowitz, ME; Jenkins, JJ; Kellie, SJ; Kovnar, EH; Langston, JW; Mulhern, RK; Sanford, RA1
Castello, MA; Clerico, A; Deb, G; Dominici, C; Donfrancesco, A; Fidani, P1
Gutjahr, P; Huber, A1

Reviews

5 review(s) available for etoposide and Medulloblastoma

ArticleYear
Medulloblastomas and central nervous system primitive neuroectodermal tumors.
    Current treatment options in oncology, 2003, Volume: 4, Issue:6

    Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Cerebellar Neoplasms; Cisplatin; Cyclophosphamide; Emergency Medical Services; Etoposide; Humans; Life Style; Lomustine; Medulloblastoma; Neuroectodermal Tumors, Primitive; Neurosurgical Procedures; Radiotherapy; Self-Help Groups; Social Support; Spinal Puncture; Vincristine

2003
[Chemotherapy for brain tumor].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 9

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Delivery Systems; Etoposide; Humans; Lymphoma; Medulloblastoma; Methotrexate; Neoplasms, Germ Cell and Embryonal; Nimustine; Oligodendroglioma; Platinum Compounds; Randomized Controlled Trials as Topic; Vincristine

2005
Metastatic adult medulloblastoma showing prolonged response to chemotherapy.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1999, Volume: 11, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Etoposide; Humans; Male; Medulloblastoma; Middle Aged; Neoplasm Metastasis; Remission Induction; Time Factors; Vincristine

1999
Adult medulloblastoma: multiagent chemotherapy.
    Neuro-oncology, 2001, Volume: 3, Issue:1

    Topics: Abdominal Pain; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebrospinal Fluid Shunts; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Hearing Loss, Sensorineural; Hematologic Diseases; Humans; Infratentorial Neoplasms; Life Tables; Lomustine; Male; Medulloblastoma; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Peripheral Nervous System Diseases; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Vincristine

2001
Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Remission Induction

1990

Trials

28 trial(s) available for etoposide and Medulloblastoma

ArticleYear
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).
    Neuro-oncology, 2022, 07-01, Volume: 24, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Humans; Infant; Isotretinoin; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Prospective Studies; Vincristine; Vorinostat

2022
Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
    Pediatric blood & cancer, 2020, Volume: 67, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Craniospinal Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Male; Medulloblastoma; Prognosis; Survival Rate; Vincristine

2020
High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Aug-10, Volume: 31, Issue:23

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasm Staging; Prognosis; Risk Factors; Vincristine; Young Adult

2013
Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Japanese journal of clinical oncology, 2008, Volume: 38, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Analysis

2008
A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
    International journal of radiation oncology, biology, physics, 2009, Jul-15, Volume: 74, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Central Nervous System Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Vincristine; Young Adult

2009
High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.
    Neuro-oncology, 2010, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Medulloblastoma; Neoplasm Recurrence, Local; Quality of Life; Radiotherapy; Salvage Therapy; Thiotepa; Young Adult

2010
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.
    European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:16

    Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Dacarbazine; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Medulloblastoma; Neoplasm Recurrence, Local; Temozolomide; Treatment Outcome

2010
Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience.
    Journal of neuro-oncology, 2012, Volume: 106, Issue:3

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Etoposide; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Medulloblastoma; Middle Aged; Survival Analysis

2012
Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
    Medical and pediatric oncology, 2002, Volume: 39, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Medulloblastoma; Methotrexate; Neoplasms, Germ Cell and Embryonal; Prognosis; Treatment Outcome

2002
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Apr-15, Volume: 21, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Male; Medulloblastoma; Neoadjuvant Therapy; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; United Kingdom; Vincristine

2003
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
    International journal of radiation oncology, biology, physics, 2004, Mar-15, Volume: 58, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Male; Medulloblastoma; Proportional Hazards Models; Survival Rate; Treatment Outcome; Vincristine

2004
Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Dec-15, Volume: 22, Issue:24

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leucovorin; Male; Medulloblastoma; Mesna; Methotrexate; Risk Factors; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vincristine

2004
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
    The New England journal of medicine, 2005, Mar-10, Volume: 352, Issue:10

    Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Etoposide; Follow-Up Studies; Humans; Infant; Intelligence; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuropsychological Tests; Postoperative Care; Proportional Hazards Models; Remission Induction; Survival Analysis; Vincristine

2005
Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:11

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dementia, Vascular; Etoposide; Humans; Infant; Magnetic Resonance Imaging; Medulloblastoma; Methotrexate

2005
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Oct-20, Volume: 23, Issue:30

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Glioma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive, Peripheral; Survival Rate; Treatment Outcome; Vincristine

2005
Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031.
    International journal of radiation oncology, biology, physics, 2006, Apr-01, Volume: 64, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cranial Irradiation; Etoposide; Humans; Infratentorial Neoplasms; Medulloblastoma; Quality Assurance, Health Care; Radiotherapy; Spinal Neoplasms; Survival Rate

2006
High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
    Pediatric blood & cancer, 2007, Volume: 48, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Contraindications; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Infections; Kaplan-Meier Estimate; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Sepsis; Supratentorial Neoplasms; Transplantation, Autologous; Treatment Outcome; Vincristine

2007
Pilot study of ifosfamide/carboplatin/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2007, Volume: 23, Issue:4

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Peripheral Blood Stem Cell Transplantation; Salvage Therapy

2007
Pre-irradiation chemotherapy in high risk medulloblastoma.
    Journal of the Egyptian National Cancer Institute, 2006, Volume: 18, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Medulloblastoma; Radiotherapy; Radiotherapy, Adjuvant; Risk Factors; Survival Analysis

2006
Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine

1995
Carboplatin and VP 16 in medulloblastoma: a phase II Study of the French Society of Pediatric Oncology (SFOP).
    Medical and pediatric oncology, 1994, Volume: 23, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Medulloblastoma; Treatment Outcome

1994
[Usefulness and problems of high dose chemotherapy using CBDCA, VP-16, and MCNU with peripheral blood stem cell transplantation in pediatric malignant brain tumors].
    No to shinkei = Brain and nerve, 1996, Volume: 48, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Nitrosourea Compounds

1996
[In vivo effect of etoposide on the pharmacokinetics of methotrexate].
    Orvosi hetilap, 1996, Oct-13, Volume: 137, Issue:41

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Clinical Protocols; Dose-Response Relationship, Drug; Drug Interactions; Etoposide; Humans; Medulloblastoma; Methotrexate

1996
Chronic oral VP-16 for recurrent medulloblastoma.
    Pediatric neurology, 1997, Volume: 17, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Time Factors

1997
Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
    Journal of neuro-oncology, 1998, Volume: 39, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Deafness; Disease Progression; Disease-Free Survival; Etoposide; Follow-Up Studies; Glioma; Hearing Loss; Hematologic Diseases; Humans; Ifosfamide; Infections; Life Tables; Lomustine; Medulloblastoma; Methotrexate; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Vincristine

1998
Effect of etoposide on the pharmacokinetics of methotrexate in vivo.
    Anti-cancer drugs, 1998, Volume: 9, Issue:9

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Etoposide; Humans; Leucovorin; Medulloblastoma; Methotrexate; Mitolactol; Procarbazine

1998
Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours.
    British journal of cancer, 2001, Jun-01, Volume: 84, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Chromatography, High Pressure Liquid; Etoposide; Female; Half-Life; Humans; Injections, Intraventricular; Male; Medulloblastoma; Neoplasm Metastasis

2001
Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.
    Journal of neuro-oncology, 1991, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Cisplatin; Cytarabine; Drug Evaluation; Ependymoma; Etoposide; Female; Glioma; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pinealoma; Probability; Prognosis

1991

Other Studies

81 other study(ies) available for etoposide and Medulloblastoma

ArticleYear
Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.
    Pediatric blood & cancer, 2020, Volume: 67, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Medulloblastoma; Melphalan; Methotrexate; Prognosis; Prospective Studies; Registries; Survival Rate

2020
GRK2 promotes growth of medulloblastoma cells and protects them from chemotherapy-induced apoptosis.
    Scientific reports, 2019, 09-25, Volume: 9, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cerebellar Neoplasms; Cisplatin; Etoposide; G-Protein-Coupled Receptor Kinase 2; HEK293 Cells; Humans; Medulloblastoma; Phosphorylation

2019
Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation.
    Journal of the Egyptian National Cancer Institute, 2020, Feb-18, Volume: 32, Issue:1

    Topics: Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Etoposide; Female; Glomerular Filtration Rate; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Retrospective Studies; Rhabdoid Tumor; Teratoma; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome

2020
Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study.
    BMC cancer, 2020, Aug-12, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Medulloblastoma; Middle Aged; Neutropenia; Progression-Free Survival; Radiotherapy; Rare Diseases; Risk; Thrombocytopenia; Young Adult

2020
PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFκB.
    Scientific reports, 2017, 04-11, Volume: 7, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Carrier Proteins; Cell Line, Tumor; Cisplatin; Etoposide; Glioblastoma; HEK293 Cells; Humans; Medulloblastoma; NF-kappa B

2017
A case of molecularly profiled extraneural medulloblastoma metastases in a child.
    BMC medical genetics, 2018, 01-17, Volume: 19, Issue:1

    Topics: Chemotherapy, Adjuvant; Child, Preschool; Craniospinal Irradiation; Cyclophosphamide; Dose-Response Relationship, Radiation; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Isotretinoin; Magnetic Resonance Imaging; Male; Medulloblastoma; N-Myc Proto-Oncogene Protein; Postoperative Period; Proto-Oncogene Proteins c-myc; Vincristine

2018
Outcome of newly diagnosed high risk medulloblastoma treated with carboplatin, vincristine, cyclophosphamide and etoposide.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2018, Volume: 56

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Humans; Infant; Medulloblastoma; Vincristine

2018
Old drugs still work! Oral etoposide in a relapsed medulloblastoma.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2019, Volume: 35, Issue:5

    Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Etoposide; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local

2019
Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.
    BMC cancer, 2019, Apr-03, Volume: 19, Issue:1

    Topics: Cell Cycle; Cell Cycle Proteins; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cerebellar Neoplasms; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Medulloblastoma; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Radiation Tolerance

2019
Human Sialic acid O-acetyl esterase (SIAE) - mediated changes in sensitivity to etoposide in a medulloblastoma cell line.
    Scientific reports, 2019, 06-13, Volume: 9, Issue:1

    Topics: Acetylation; Acetylesterase; Acetyltransferases; Brain Neoplasms; Cell Line, Tumor; Child; Clone Cells; Etoposide; Gangliosides; Humans; Medulloblastoma; Membrane Potential, Mitochondrial

2019
The histone deacetylase inhibitor sodium butyrate promotes cell death and differentiation and reduces neurosphere formation in human medulloblastoma cells.
    Molecular neurobiology, 2013, Volume: 48, Issue:3

    Topics: Biomarkers, Tumor; Brain Neoplasms; Butyric Acid; Cell Death; Cell Differentiation; Cell Survival; Etoposide; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Medulloblastoma; RNA, Messenger; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Stem Cell Assay

2013
Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2013, Volume: 29, Issue:7

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cranial Irradiation; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Medulloblastoma; Melphalan; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Quality of Life; Radiotherapy; Retrospective Studies; Salvage Therapy; Temozolomide; Young Adult

2013
Unusual case of recurrent extraneural metastatic medulloblastoma in a young adult: durable complete remission with Ewing sarcoma chemotherapy regimen and consolidation with autologous bone marrow transplantation and local radiation.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-01, Volume: 31, Issue:19

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Cerebellar Neoplasms; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Induction Chemotherapy; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Medulloblastoma; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Recurrence; Sarcoma, Ewing; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine

2013
Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2013, Volume: 29, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Irinotecan; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive, Peripheral; Radiotherapy; Retrospective Studies; Salvage Therapy; Vincristine; Young Adult

2013
[Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].
    Magyar onkologia, 2013, Volume: 57, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow; Brain Neoplasms; Brain Stem Neoplasms; Carcinoma; Celecoxib; Cerebellar Neoplasms; Child; Child, Preschool; Choroid Plexus Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Hungary; Ischemic Attack, Transient; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Optic Nerve Glioma; Pyrazoles; Quality of Life; Retrospective Studies; Sulfonamides; Thalidomide; Treatment Outcome

2013
PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells.
    Cancer biology & therapy, 2014, Jun-01, Volume: 15, Issue:6

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cerebellar Neoplasms; Child; Cisplatin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Humans; Medulloblastoma; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vincristine

2014
Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Genes, p53; Humans; Medulloblastoma; MicroRNAs; Mutation; Up-Regulation

2014
In vitro co-culture model of medulloblastoma and human neural stem cells for drug delivery assessment.
    Journal of biotechnology, 2015, Jul-10, Volume: 205

    Topics: Antineoplastic Agents; Brain Neoplasms; Cell Survival; Cells, Cultured; Coculture Techniques; Drug Screening Assays, Antitumor; Etoposide; Humans; Medulloblastoma; Models, Biological; Neural Stem Cells; Spheroids, Cellular

2015
Cavernous angioma after chemotherapy for desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2016, Volume: 32, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cerebellar Neoplasms; Child, Preschool; Cisplatin; Cyclophosphamide; Ectodermal Dysplasia; Etoposide; Hemangioma, Cavernous, Central Nervous System; Humans; Infant; Intracranial Hemorrhages; Male; Medulloblastoma; Melphalan; Methotrexate; Neurosurgical Procedures; Peripheral Blood Stem Cell Transplantation; Vincristine

2016
Successful Treatment with Etoposide Base after an Acute Hypersensitivity Reaction to Etoposide Phosphate.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:3

    Topics: Acute Disease; Benzyl Alcohols; Carboplatin; Child, Preschool; Drug Hypersensitivity; Etoposide; Female; Humans; Infusions, Intravenous; Medulloblastoma; Organophosphorus Compounds

2016
Successful Use of Dose Dense Neoadjuvant Chemotherapy and Sodium Valproate with Minimal Toxicity in an Infant with Medulloblastoma in Extremely Poor General Condition.
    World neurosurgery, 2016, Volume: 93

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Critical Care; Cyclophosphamide; Drug Administration Schedule; Etoposide; Histone Deacetylase Inhibitors; Humans; Infant; Longitudinal Studies; Male; Medulloblastoma; Neoadjuvant Therapy; Neurocognitive Disorders; Neurodevelopmental Disorders; Treatment Outcome; Valproic Acid; Vincristine

2016
The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibition.
    Oncotarget, 2017, Jul-18, Volume: 8, Issue:29

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Humans; Indazoles; Medulloblastoma; Molecular Targeted Therapy; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides

2017
Multivariate survival analysis of children with medulloblastoma--a single-center experience.
    Pediatric hematology and oncology, 2008, Volume: 25, Issue:7

    Topics: Adolescent; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Infant; Male; Medulloblastoma; Multivariate Analysis; Radiation-Sensitizing Agents; Survival Analysis

2008
No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    International journal of radiation oncology, biology, physics, 2009, Apr-01, Volume: 73, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Salvage Therapy; Thiotepa; Vincristine; Young Adult

2009
Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Feb-01, Volume: 27, Issue:4

    Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Metastasis; Radiotherapy Dosage; Survival Rate; Treatment Outcome

2009
Detection of drug-induced cellular changes using confocal Raman spectroscopy on patterned single-cell biosensors.
    The Analyst, 2009, Volume: 134, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Biosensing Techniques; Cell Adhesion; Cell Line, Tumor; Cell Survival; Etoposide; Flow Cytometry; Gold; Humans; In Situ Nick-End Labeling; Medulloblastoma; Microarray Analysis; Spectrum Analysis, Raman; Time Factors

2009
The alkylphospholipid perifosine induces apoptosis and p21-mediated cell cycle arrest in medulloblastoma.
    Molecular cancer research : MCR, 2009, Volume: 7, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Survival; Cerebellar Neoplasms; Child; Cyclin-Dependent Kinase Inhibitor p21; Etoposide; Humans; Isoenzymes; Medulloblastoma; Phosphorylcholine; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Transfection

2009
Tissue factor mediates the HGF/Met-induced anti-apoptotic pathway in DAOY medulloblastoma cells.
    Journal of neuro-oncology, 2010, Volume: 97, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Etoposide; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Inhibitor of Apoptosis Proteins; Medulloblastoma; Microtubule-Associated Proteins; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-met; RNA, Small Interfering; Signal Transduction; Survivin; Thromboplastin; Time Factors; Transfection; Tumor Suppressor Protein p53

2010
[The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases].
    No shinkei geka. Neurological surgery, 2010, Volume: 38, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Ependymoma; Etoposide; Female; Glioblastoma; Hematologic Diseases; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Retrospective Studies

2010
p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma.
    Cell death & disease, 2010, May-13, Volume: 1

    Topics: Caspases; Cell Death; Cell Line, Tumor; Cerebellar Neoplasms; Drug Screening Assays, Antitumor; Etoposide; Humans; Medulloblastoma; Models, Biological; NF-kappa B; Phosphorylation; Receptors, Death Domain; Transcription Factor RelA; Tumor Suppressor Protein p53

2010
Combination chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma: single-institute experience and differences in efficacy for subgroups of medulloblastoma.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2011, Volume: 27, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Retrospective Studies; Treatment Outcome

2011
Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
    Neuro-oncology, 2011, Volume: 13, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Magnetic Resonance Imaging; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy; Remission Induction; Survival Rate; Vincristine

2011
Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis.
    Current molecular medicine, 2011, Volume: 11, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Carrier Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; DNA Repair; Docosahexaenoic Acids; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hyaluronan Receptors; Inhibitor of Apoptosis Proteins; Medulloblastoma; Mitogen-Activated Protein Kinase 14; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Survivin; Transcription Factors

2011
RASSF1A and the BH3-only mimetic ABT-737 promote apoptosis in pediatric medulloblastoma cell lines.
    Neuro-oncology, 2011, Volume: 13, Issue:12

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Blotting, Western; Caspases; Cell Line, Tumor; Cerebellar Neoplasms; Child; Cisplatin; Etoposide; Humans; Immunoenzyme Techniques; Medulloblastoma; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tumor Suppressor Proteins

2011
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.
    Anti-cancer drugs, 2012, Volume: 23, Issue:3

    Topics: Administration, Metronomic; Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cerebellar Neoplasms; Cytarabine; Etoposide; Humans; Injections, Spinal; Liposomes; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neutropenia; Pyrazoles; Sulfonamides; Thalidomide; Treatment Outcome

2012
Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
    Journal of complementary & integrative medicine, 2012, Aug-10, Volume: 9

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Curcuma; Curcumin; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Glioblastoma; Humans; Inhibitory Concentration 50; Medulloblastoma; Phytotherapy; Plant Extracts; Plants, Medicinal; Rhizome; Temozolomide

2012
Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.
    Neuro-oncology, 2013, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Male; Medulloblastoma; Melphalan; Neoplasm Staging; Prognosis; Prospective Studies; Radiotherapy Dosage; Risk Factors; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous; Young Adult

2013
Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma.
    Bone marrow transplantation, 2002, Volume: 30, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Thiotepa; Transplantation, Autologous; Treatment Outcome

2002
Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:3

    Topics: Adult; Allopurinol; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Cisplatin; Etoposide; Fluid Therapy; Humans; Liver Neoplasms; Male; Medulloblastoma; Renal Dialysis; Tumor Lysis Syndrome

2003
Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome.
    Medical and pediatric oncology, 2003, Volume: 41, Issue:1

    Topics: Abnormalities, Multiple; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Cycle Proteins; Child; Chromosome Breakage; Cisplatin; Cytarabine; Death, Sudden, Cardiac; Etoposide; Fatal Outcome; Humans; Ifosfamide; Infratentorial Neoplasms; Male; Medulloblastoma; Methotrexate; Nuclear Proteins; Polymerase Chain Reaction; Syndrome

2003
Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:3

    Topics: Adenoviridae; Animals; Apoptosis; Brain; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Etoposide; Green Fluorescent Proteins; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Medulloblastoma; Mice; Mice, Nude; Models, Biological; Neoplasm Transplantation; Neurons; Repressor Proteins; Stem Cells; Time Factors; Transcription Factors; Transcription, Genetic

2005
[Medulloblastoma with mandibular metastasis after complete remission of the central nervous system lesions].
    No to shinkei = Brain and nerve, 2005, Volume: 57, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cerebellar Neoplasms; Cerebral Ventricle Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Etoposide; Humans; Magnetic Resonance Imaging; Male; Mandibular Neoplasms; Medulloblastoma; Nimustine; Remission Induction

2005
Medulloblastoma in two successive pregnancies.
    Journal of neuro-oncology, 2005, Volume: 73, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Medulloblastoma; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Treatment Outcome; Vincristine

2005
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jul-20, Volume: 23, Issue:21

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Male; Medulloblastoma; Radiotherapy Dosage; Spinal Canal; Survival Rate

2005
Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
    Pediatric blood & cancer, 2007, Volume: 49, Issue:2

    Topics: Administration, Oral; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Brain Abscess; Carboplatin; Cerebral Ventricle Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Diagnostic Errors; Etoposide; Humans; Immunocompromised Host; Infusions, Intravenous; Lomustine; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuroaspergillosis; Pyrimidines; Surgical Wound Infection; Triazoles; Vincristine; Voriconazole

2007
Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Pediatric blood & cancer, 2007, Volume: 48, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cognition Disorders; Cranial Irradiation; Cyclophosphamide; Developmental Disabilities; Disease-Free Survival; Ependymoma; Etoposide; Follow-Up Studies; Ganglioglioma; Glioma; Humans; Infant; Medulloblastoma; Mitotic Index; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Peripheral Blood Stem Cell Transplantation; Quadriplegia; Retrospective Studies; Sensation Disorders; Spinal Cord Neoplasms; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine

2007
Stereotactic radiation therapy with chemotherapy in the management of recurrent medulloblastomas.
    Pediatric neurosurgery, 2006, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Male; Medulloblastoma; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Radiosurgery; Radiotherapy Dosage; Retrospective Studies

2006
Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
    International journal of oncology, 2006, Volume: 28, Issue:3

    Topics: Acetylation; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Butyrates; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor; DNA Fragmentation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Etoposide; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Medulloblastoma; Membrane Glycoproteins; Membrane Potentials; Mitochondrial Membranes; Radiation-Sensitizing Agents; Radiation, Ionizing; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Vincristine; Vorinostat

2006
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.
    European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Humans; Medulloblastoma; Postoperative Care; Prospective Studies; Risk Factors; Treatment Outcome

2006
Enhanced expression of DNA topoisomerase II genes in human medulloblastoma and its possible association with etoposide sensitivity.
    Journal of neuro-oncology, 2007, Volume: 84, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; DNA; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Etoposide; Gene Expression; Gene Expression Profiling; Humans; Immunohistochemistry; Medulloblastoma; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2007
Clinical and molecular parameters for risk stratification in Mexican children with medulloblastoma.
    Archives of medical research, 2007, Volume: 38, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Medulloblastoma; Mexico; Probability; Receptor, ErbB-2; Risk; Risk Assessment; Survival Rate; Time Factors

2007
Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Feasibility Studies; Ganglioglioma; Humans; Infant; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Quality of Life; Retrospective Studies; Thiotepa; Treatment Outcome; Vincristine

2008
Multiagent chemotherapy studied in a xenograft model of medulloblastoma/primitive neuroectodermal tumour: analysis of the VETOPEC regimen.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2008, Volume: 15, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child, Preschool; Cyclophosphamide; Etoposide; Humans; Medulloblastoma; Mice; Mice, Nude; Neuroectodermal Tumors, Primitive; Time Factors; Vincristine; Xenograft Model Antitumor Assays

2008
High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
    Cancer, 2008, Apr-15, Volume: 112, Issue:8

    Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Cisplatin; Cohort Studies; Disease Progression; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Male; Medulloblastoma; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Procarbazine; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous

2008
In vivo effects of recombinant human lymphotoxin on human medulloblastoma xenograft: enhancement of antitumor activity of etoposide.
    Biotherapy (Dordrecht, Netherlands), 1994, Volume: 8, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Drug Synergism; Etoposide; Female; Humans; Indicators and Reagents; Lymphotoxin-alpha; Medulloblastoma; Mice; Mice, Inbred BALB C; Mice, Nude; Recombinant Proteins; Subrenal Capsule Assay; Tumor Necrosis Factor-alpha

1994
[Intensive and high-dose chemotherapy with peripheral blood stem cell transfusion for pediatric malignant brain tumor].
    No shinkei geka. Neurological surgery, 1995, Volume: 23, Issue:5

    Topics: Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Ependymoma; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Nitrosourea Compounds; Pinealoma

1995
Etoposide treatment in recurrent medulloblastoma.
    Neuropediatrics, 1994, Volume: 25, Issue:1

    Topics: Adult; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Frontal Lobe; Humans; Male; Medulloblastoma; Neoplasm Metastasis; Prognosis; Recurrence; Spinal Cord Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

1994
Isolation of parainfluenza virus type 3 from cerebrospinal fluid associated with aseptic meningitis.
    American journal of clinical pathology, 1993, Volume: 99, Issue:6

    Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Cerebellar Neoplasms; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Female; Humans; Infant; Macaca mulatta; Male; Medulloblastoma; Meningitis, Aseptic; Parainfluenza Virus 3, Human; Vincristine

1993
Preirradiation chemotherapy for very young children with brain tumors.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 1993, Volume: 9, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Ependymoma; Etoposide; Female; Follow-Up Studies; Glioblastoma; Humans; Infant; Male; Medulloblastoma; Neurologic Examination; Vinblastine

1993
Carboplatin and cisplatin in medulloblastoma at diagnosis: "comparable efficacy?".
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:5

    Topics: Antineoplastic Agents; Carboplatin; Child; Etoposide; Humans; Medulloblastoma; Treatment Outcome

1996
Response of recurrent medulloblastoma to low-dose oral etoposide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:6

    Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local

1996
Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
    Neurologia medico-chirurgica, 1996, Volume: 36, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cranial Fossa, Posterior; Cranial Irradiation; Disease-Free Survival; Etoposide; Female; Hearing Loss; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Pilot Projects; Radiotherapy, Adjuvant; Remission Induction; Skull Base Neoplasms

1996
[A patient with lung metastasis of medulloblastoma].
    Nihon Kyobu Shikkan Gakkai zasshi, 1996, Volume: 34, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Lung Neoplasms; Male; Medulloblastoma; Spinal Cord Neoplasms

1996
Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.
    Journal of neuro-oncology, 1997, Volume: 32, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Medulloblastoma; Methotrexate; Remission Induction; Vincristine

1997
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Neoplasm Recurrence, Local; Survival Analysis; Thiotepa; Transplantation, Autologous

1998
[Meningoradiculitis revealing an occult medulloblastoma-PNET in an adult].
    Revue neurologique, 1998, Volume: 154, Issue:6-7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Etoposide; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Meningitis; Methotrexate; Middle Aged; Neuroectodermal Tumors, Primitive; Oculomotor Nerve; Polyradiculopathy

1998
Etoposide-carboplatin association as 'emergency' up-front chemotherapy in a case of life-threatening adult medulloblastoma.
    Journal of neuro-oncology, 1998, Volume: 39, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Emergencies; Etoposide; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma

1998
Survival of patients with medulloblastoma treated with carboplatin and etoposide before and after radiotherapy.
    Archives of medical research, 1998,Winter, Volume: 29, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Humans; Infant; Medulloblastoma; Remission Induction

1998
Pharmacokinetics of etoposide in plasma and cerebrospinal fluid in the space left by tumor removal.
    The Annals of pharmacotherapy, 1999, Volume: 33, Issue:1

    Topics: Adolescent; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Combined Modality Therapy; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma

1999
Metastatic medulloblastoma in 10-year-old girl treated successfully with chemotherapy without radiotherapy.
    Journal of neuro-oncology, 1999, Volume: 45, Issue:1

    Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Medulloblastoma

1999
High-dose chemotherapy with autologous stem cell support in an adult with bone marrow relapse of medulloblastoma.
    Bone marrow transplantation, 2000, Volume: 26, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Busulfan; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Thiotepa; Transplantation, Autologous

2000
[Post-operative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of German prospective randomised trial HIT'91].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2001, Volume: 5, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Drug Administration Schedule; Etoposide; Germany; Humans; Ifosfamide; Lomustine; Medulloblastoma; Mesna; Nervous System Diseases; Neutropenia; Postoperative Period; Prospective Studies; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Treatment Outcome; Vincristine

2001
Shunt-related abdominal metastases in an infant with medulloblastoma: long-term remission by systemic chemotherapy and surgery.
    Journal of neuro-oncology, 2001, Volume: 52, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Hydrocephalus; Hydroxyurea; Infant; Liver Neoplasms; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pelvic Neoplasms; Peritoneal Neoplasms; Remission Induction; Ventriculoperitoneal Shunt

2001
Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction.
    Neuro-oncology, 2001, Volume: 3, Issue:4

    Topics: Adolescent; Animals; Antineoplastic Agents; Apoptosis; Astrocytoma; Brain Neoplasms; Cell Survival; Child; Child, Preschool; Colorimetry; Culture Media, Conditioned; DNA, Complementary; Drug Resistance, Neoplasm; Etoposide; Fas Ligand Protein; fas Receptor; Female; Ganglioglioma; Germinoma; Glioblastoma; Humans; Infant; Jurkat Cells; Male; Medulloblastoma; Membrane Glycoproteins; Mice; Neoplasm Proteins; Neuroblastoma; Neuroectodermal Tumors, Primitive; Pineal Gland; Pinealoma; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured

2001
Preliminary results of dose intensive pre-irradiation chemotherapy in patients older than 10 years of age with high risk medulloblastoma and supratentorial primitive neuroectodermal tumors.
    Medical and pediatric oncology, 2002, Volume: 38, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Medical Records; Medulloblastoma; Neoadjuvant Therapy; Neoplasm Staging; Neuroectodermal Tumors; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2002
Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation.
    Journal of neuro-oncology, 1992, Volume: 13, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Bone Neoplasms; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Etoposide; Graft vs Host Disease; Humans; Lymphatic Metastasis; Male; Medulloblastoma; Prevalence; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine

1992
[A case of extraneural metastasis of medulloblastoma successfully treated with cisplatin and etoposide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child, Preschool; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Infusions, Intravenous; Male; Medulloblastoma; Remission Induction; Thoracic Neoplasms

1992
Treatment of early recurrent medulloblastoma in children with cisplatin and etoposide: a preliminary report.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 1992, Volume: 8, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neurologic Examination; Tomography, X-Ray Computed

1992
Comparison of in vitro activity of epipodophyllotoxins with other chemotherapeutic agents in human medulloblastomas.
    British journal of cancer, 1991, Volume: 64, Issue:6

    Topics: Alkylating Agents; Amsacrine; Cell Division; Cell Survival; Cross-Linking Reagents; Cytarabine; DNA Damage; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Humans; Hydroxyurea; In Vitro Techniques; Karyotyping; Medulloblastoma; Teniposide; Tumor Cells, Cultured; Vincristine

1991
High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors.
    The American journal of pediatric hematology/oncology, 1990,Fall, Volume: 12, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Diseases; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Drug Evaluation; Etoposide; Glioblastoma; Hearing Loss, Sensorineural; Humans; Infant; Medulloblastoma; Remission Induction

1990
Treatment of medulloblastoma.
    The Journal of pediatrics, 1990, Volume: 116, Issue:1

    Topics: Adolescent; Cerebellar Neoplasms; Etoposide; Humans; Male; Medulloblastoma; Remission Induction

1990